0303cm中醫(yī)1506任傳云宣肺通竅湯聯(lián)合補(bǔ)中益氣丸內(nèi)服辨治過(guò)敏性鼻炎臨床研究

任（中大學(xué)附屬東直門(mén)醫(yī)院呼吸科（P＜0.05（P＜0.05(77.8%)（P＜0.0568.6（P＜0.05TheclinicaleffectofXuanFeiTongQiTangcombinedBuZhongYiQiWaninthetreatmentofanaphylactic任（中大學(xué)附屬東直門(mén)醫(yī)院呼吸科請(qǐng)將作者和單位名稱(chēng)翻譯成英【】Objective:ToobservetheclinicaleffectofXuanFeiTongQiTangcombinedwithBuZhongYiQiWaninthetreatmentofanaphylacticrhinitis.Methods:90casesofanaphylacticrhinitisdiagnosedinourhospitalbetweenJanuary2012andJanuary2014,wererandomlydividedintothetreatmentgroupandthecontrolgroup.Thecontrolgroupwasgivenconventionaldrugstreatment,andthetreatmentgroupwasgivenXuanFeiTongQiTangcombinedwithBuZhongYiQiWan.Aftertreatmentforonemonth,thesymptomsandsignsoftraditionalChinesemedicineandthelaboratoryindexesofpretherapyandpost-treatmentinthetwogroupswereinvestigatedandyzed.Followedupfor6months,therecurrencerateandadversereactionsofthetwogroupscomparedandyzed.Result:Comparedwithbeforetreatment,theintegralofthesymptomsandsignsinthetwogroupsweresignificantlyreduced(P<0.05);thescoresofthetreatmentgroupwassignificantlylowerthanthatofthecontrolgroupaftertreatment.Theefficiencyandtotaleffectiverateintreatmentgroupweresignificantlyhigherthanthoseofthecontrolgroup(P<0.05);therecurrencerateofthetreatmentgroupwas19.0%,whichwassignificantlylowerthanthatofthecontrolgroup(68.6%)(P<0.05).Conclusion:TheapplicationofXuanFeiTongQiTangcombinedwithBuZhongYiQiWaninthetreatmentofanaphylacticrhinitisiscansignificantlyimprovetheclinicalsymptomswithreliablerecentandforwardcurativeeffect,worthclinicalpromotion.【Keywords】XuanFeiTongQiTang;BuZhongYiQiWan;AnaphylacticClinical過(guò)敏性鼻炎（AllergicRhinitis,AR）又稱(chēng)為變應(yīng)性鼻炎，是一種由多種因素引起的I型反應(yīng)炎癥性疾病，患者在臨多表現(xiàn)為鼻塞、鼻癢、陣發(fā)性噴201212014190例過(guò)敏性鼻炎照組，每組各45例。治療組男23例，女22例；18～65歲，平均（37.5±8.3）1～6年，平均（2.7±0.5）2223例；年患者在、、病程等一般臨床資料上無(wú)統(tǒng)計(jì)學(xué)意義（P＞0.05。所有患者均在18～65歲，近半個(gè)月未使用任何抗過(guò)敏藥物，患者均在知情在嚴(yán)重精神和語(yǔ)言者，排除重度鼻中隔偏曲者及妊娠期患者。生黃芪20g，白芍12g，花10g，蟬衣6g，炙麻黃3g。逐癥加減用藥：氣逆白芷。以水煎服，一劑，分早晚各一次，以?xún)芍転橐化煶蹋B續(xù)用藥兩個(gè)療Z13021082，規(guī)格：12克)，3次/d，以?xún)芍転橐化煶?，連續(xù)用藥兩個(gè)療程。對(duì)照，10mg/連續(xù)用藥兩個(gè)療程。治療期間用其他藥物。2個(gè)療程結(jié)束后停藥，隨訪1年前總分x100。與治療前相比，兩組患者治療后癥狀體征積分均顯著低于治療前評(píng)分（P＜0.51組例數(shù)治療前癥狀體征治療后癥狀體征治療對(duì)照內(nèi)比較中，與治療前相比，*P＜0.05；與對(duì)照組相（P＞0.05表2兩組療效比較組例數(shù)顯效總有顯效有效率治療3對(duì)照9復(fù)（P＞0.053組 例數(shù)復(fù)發(fā)例復(fù)發(fā)治療 8對(duì)照 3 應(yīng)[7]，在花粉、灰塵、塵螨、真菌、皮毛等過(guò)敏原刺激作用下，患者體內(nèi)產(chǎn)生IgE得到臨床的的認(rèn)可和患者的接受。祖國(guó)醫(yī)學(xué)將過(guò)敏性鼻炎歸屬為“鼻鼽”范疇，中醫(yī)辨證認(rèn)為鼻為肺竅肺氣虛寒，衛(wèi)表失固,腠理疏松,風(fēng)寒侵入，肺氣不得通調(diào),而脾虛,則無(wú)力上輸于肺,170-[2].中西醫(yī)結(jié)合治療過(guò)敏性鼻炎60例[J].中醫(yī),2010,30(4):385-[3]遠(yuǎn),.針刺治療過(guò)敏性鼻炎研究進(jìn)展[J].中醫(yī),2013,變應(yīng)性鼻炎和治療指南[J].中國(guó)臨床醫(yī)生,2010,38(6):67-中民 .中藥新藥臨床研究指導(dǎo)原則[M].人民衛(wèi)生中華耳鼻咽喉頭頸外科雜志編輯中華醫(yī)學(xué)會(huì)耳鼻咽喉科分會(huì).變應(yīng)性鼻炎的診治原則和方案(2004年,蘭州)[J].中華耳鼻咽喉頭頸外科雜志,2005.40(3):166-，盧競(jìng).反應(yīng)性鼻炎[J].世界醫(yī)學(xué)雜志，2002，6(19):16-.中西醫(yī)結(jié)合治療過(guò)敏性鼻炎臨床觀察[J].中醫(yī)學(xué)院學(xué)報(bào),23(5):63-,,.補(bǔ)氣抗敏湯治療過(guò)敏性鼻炎30例[J].中醫(yī),2008,28(4):51-52.，，.宣肺通竅湯聯(lián)合西替利嗪對(duì)常年性變應(yīng)性鼻炎患IL-17、IL-10